Tokyo Tape
Sign in
← BrightPath Biotherapeutics

Annual report

4594.TEDINET S100VZBU
Period2024-04-01 → 2025-03-31
Filed2025-06-19
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 78
MetricValuePeriodScopeSource row
Revenue¥1m2024-04-01 → 2025-03-31StandaloneNet sales
Revenue¥72,0002023-04-01 → 2024-03-31StandaloneNet sales
Revenue¥5m2022-04-01 → 2023-03-31dStandaloneNet sales (5-year summary)
Revenue¥15m2021-04-01 → 2022-03-31dStandaloneNet sales (5-year summary)
Revenue¥3m2020-04-01 → 2021-03-31dStandaloneNet sales (5-year summary)
Operating income−¥1.2bn2024-04-01 → 2025-03-31StandaloneOperating income
Operating income−¥1.2bn2023-04-01 → 2024-03-31StandaloneOperating income
Ordinary income−¥1.1bn2024-04-01 → 2025-03-31StandaloneOrdinary income
Ordinary income−¥1.2bn2023-04-01 → 2024-03-31StandaloneOrdinary income
Ordinary income−¥1.5bn2022-04-01 → 2023-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.5bn2021-04-01 → 2022-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.7bn2020-04-01 → 2021-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥1.1bn2024-04-01 → 2025-03-31StandaloneIncome before income taxes
Profit before tax−¥1.2bn2023-04-01 → 2024-03-31StandaloneIncome before income taxes
Net income−¥1.2bn2024-04-01 → 2025-03-31StandaloneProfit loss
Net income−¥1.2bn2023-04-01 → 2024-03-31StandaloneProfit loss
Net income−¥1.5bn2022-04-01 → 2023-03-31dStandaloneNet income loss (5-year summary)
Net income−¥1.5bn2021-04-01 → 2022-03-31dStandaloneNet income loss (5-year summary)
Net income−¥1.7bn2020-04-01 → 2021-03-31dStandaloneNet income loss (5-year summary)
Total assets¥1.1bnat 2025-03-31StandaloneAssets
Total assets¥1.2bnat 2024-03-31StandaloneAssets
Total assets¥1.7bnat 2023-03-31dStandaloneTotal assets (5-year summary)
Total assets¥2.8bnat 2022-03-31dStandaloneTotal assets (5-year summary)
Total assets¥3.7bnat 2021-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥196mat 2025-03-31StandaloneLiabilities
Total liabilities¥251mat 2024-03-31StandaloneLiabilities
Net assets / equity¥925mat 2025-03-31StandaloneNet assets
Net assets / equity¥979mat 2024-03-31StandaloneNet assets
Net assets / equity¥1.6bnat 2023-03-31dStandaloneNet assets
Net assets / equity¥2.5bnat 2022-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥3.5bnat 2021-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥810mat 2025-03-31StandaloneCash and deposits
Cash and deposits¥1.1bnat 2024-03-31StandaloneCash and deposits
Cash & equivalents¥810mat 2025-03-31StandaloneCash and cash equivalents
Cash & equivalents¥1.1bnat 2024-03-31StandaloneCash and cash equivalents
Cash & equivalents¥1.5bnat 2023-03-31dStandaloneCash and cash equivalents
Cash & equivalents¥2.3bnat 2022-03-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥3.3bnat 2021-03-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥1.3bn2024-04-01 → 2025-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.2bn2023-04-01 → 2024-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.2bn2022-04-01 → 2023-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.5bn2021-04-01 → 2022-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.8bn2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥1m2024-04-01 → 2025-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥8m2023-04-01 → 2024-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥2m2022-04-01 → 2023-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥18m2021-04-01 → 2022-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥36m2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥1.0bn2024-04-01 → 2025-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥691m2023-04-01 → 2024-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥432m2022-04-01 → 2023-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥569m2021-04-01 → 2022-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥2.1bn2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-14.122024-04-01 → 2025-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-18.212023-04-01 → 2024-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-24.92022-04-01 → 2023-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-28.552021-04-01 → 2022-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-36.142020-04-01 → 2021-03-31dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥9.98at 2025-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥13.52at 2024-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥24.6at 2023-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥45.4at 2022-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥69.1at 2021-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio80.6%at 2025-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio77.7%at 2024-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio90.9%at 2023-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio90.5%at 2022-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio93.7%at 2021-03-31dStandaloneEquity to asset ratio (5-year summary)
Shares issued90,491,300at 2025-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued70,741,300at 2024-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued62,891,200at 2023-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued55,253,100at 2022-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued50,817,500at 2021-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees24at 2025-03-31StandaloneNumber of employees
Employees24at 2024-03-31StandaloneNumber of employees
Employees32at 2023-03-31dStandaloneNumber of employees
Employees38at 2022-03-31dStandaloneNumber of employees
Employees44at 2021-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 742
ItemContextValueUnit
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E31851-000NagaiKenichiMemberText · Plus
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E31851-000NagaiKenichiMember
Original text (Japanese)(注)３
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E31851-000NakamuraNorihiroMember
Original text (Japanese)取締役創薬研究部長
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E31851-000NakamuraNorihiroMember
Original text (Japanese)中村　徳弘
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E31851-000NakamuraNorihiroMember1968-11-08
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E31851-000NakamuraNorihiroMemberText · Plus
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E31851-000NakamuraNorihiroMember
Original text (Japanese)(注)３
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E31851-000YamadaAkiraMember
Original text (Japanese)取締役
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E31851-000YamadaAkiraMember
Original text (Japanese)山田　亮
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E31851-000YamadaAkiraMember1957-03-11
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E31851-000YamadaAkiraMemberText · Plus
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E31851-000YamadaAkiraMember
Original text (Japanese)　(注)３
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E31851-000TakeuchiHirotakaMember
Original text (Japanese)取締役
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E31851-000TakeuchiHirotakaMember
Original text (Japanese)竹内　弘高
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E31851-000TakeuchiHirotakaMember1946-10-16
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E31851-000TakeuchiHirotakaMemberText · Plus
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E31851-000TakeuchiHirotakaMember
Original text (Japanese)(注)３
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E31851-000KishinoTsutomuMember
Original text (Japanese)監査役（常勤）
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E31851-000KishinoTsutomuMember
Original text (Japanese)岸野　努
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E31851-000KishinoTsutomuMember1953-01-28
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E31851-000KishinoTsutomuMemberText · Plus
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E31851-000KishinoTsutomuMember
Original text (Japanese)(注)４
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E31851-000AbeTaketoshiMember
Original text (Japanese)監査役
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E31851-000AbeTaketoshiMember
Original text (Japanese)阿部　武敏
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E31851-000AbeTaketoshiMember1944-01-29
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E31851-000AbeTaketoshiMemberText · Plus
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E31851-000AbeTaketoshiMember
Original text (Japanese)(注)４
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E31851-000YamaguchiYoshiyasuMember
Original text (Japanese)監査役
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E31851-000YamaguchiYoshiyasuMember
Original text (Japanese)山口　芳泰
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E31851-000YamaguchiYoshiyasuMember1964-02-12
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E31851-000YamaguchiYoshiyasuMemberText · Plus
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E31851-000YamaguchiYoshiyasuMember
Original text (Japanese)(注)４
Footnotes directors and corporate auditors (text)FilingDateInstant_Row1MemberText · Plus
Footnotes directors and corporate auditors (text)FilingDateInstant_Row2MemberText · Plus
Footnotes directors and corporate auditors (text)FilingDateInstant_Row3MemberText · Plus
Footnotes directors and corporate auditors (text)FilingDateInstant_Row4MemberText · Plus
Outside directors and outside corporate auditors (text)FilingDateInstantText · Plus
Audits (text)FilingDateInstantText · Plus
Remuneration for directors and other officers (text)FilingDateInstantText · Plus
Remuneration etc paid by group to each director or other officer (text)FilingDateInstantText · Plus
Shareholdings (text)FilingDateInstantText · Plus
Regulations in accordance with which financial statements have been prepared financial informationCurrentYearDurationText · Plus
Note on independent audit financial informationCurrentYearDurationText · Plus
Description of fact that consolidated financial statements have not been prepared financial informationCurrentYearDuration
Original text (Japanese)当社は子会社がありませんので、連結財務諸表を作成しておりません。
Remarkable efforts to ensure fair presentation of consolidated financial statements etc financial informationCurrentYearDurationText · Plus
Balance sheet (text)CurrentYearDurationText · Plus
Statement of income (text)CurrentYearDurationText · Plus
Detailed schedule of manufacturing cost (text)CurrentYearDurationText · Plus
Statement of changes in equity (text)CurrentYearDurationText · Plus
Statement of cash flows (text)CurrentYearDurationText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2024-03-31pass
balance sheet identitynon_consolidated 2025-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2024-03-31pass
statement vs summary · net assetsnon_consolidated 2025-03-31pass
statement vs summary · operating cash flownon_consolidated 2023-04-01/2024-03-31pass
statement vs summary · operating cash flownon_consolidated 2024-04-01/2025-03-31pass
statement vs summary · revenuenon_consolidated 2023-04-01/2024-03-31pass
statement vs summary · revenuenon_consolidated 2024-04-01/2025-03-31pass
statement vs summary · total assetsnon_consolidated 2024-03-31pass
statement vs summary · total assetsnon_consolidated 2025-03-31pass